Giammarco S, Maggi R, Di Marino L, Chiusolo P, et al. The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience. Bone Marrow Transplant 2024 Nov 21. doi: 10.1038/s41409-024-02475.
PMID: 39567768